Siga Technologies Inc SIGA
Institutional shares held
33.6 Million
314K
calls
329K
puts
Total value of holdings
$248M
$2.32M
calls
$2.43M
puts
Market Cap
$540M
73,024,096
Shares Out.
Institutional ownership
45.96%
# of Institutions
156
We take great care to ensure that the data presented and summarized in this overview for SIGA TECHNOLOGIES INC is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding SIGA
View all-
Black Rock Inc. New York, NY3.46MShares$25.6 Million0.0% of portfolio
-
First Wilshire Securities Management Inc Pasadena, CA2.65MShares$19.6 Million6.65% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.28MShares$16.9 Million0.0% of portfolio
-
Kempen Capital Management N.V. Amsterdam, P72.2MShares$16.3 Million0.24% of portfolio
-
Altra Vue Capital, LLC Bellevue, WA2.04MShares$15.1 Million2.11% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.69MShares$12.5 Million0.0% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA1.58MShares$11.7 Million0.03% of portfolio
-
Goldman Sachs Group Inc New York, NY1.53MShares$11.3 Million0.0% of portfolio
-
State Street Corp Boston, MA1.1MShares$8.17 Million0.0% of portfolio
-
Hotchkis & Wiley Capital Management LLC Los Angeles, CA1.09MShares$8.07 Million0.03% of portfolio
Latest Institutional Activity in SIGA
Top Purchases
Top Sells
About SIGA
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. has a strategic partnership with Cipla Therapeutics to deliver sustained innovation and access to antibacterial drugs primarily against biothreats. The company was incorporated in 1995 and is headquartered in New York, New York.
Insider Transactions at SIGA
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 11
2024
|
Jay Varma EVP & Chief Medical Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
7,414
-30.0%
|
$51,898
$7.86 P/Share
|
|
Jun 11
2024
|
Jay Varma EVP & Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
24,712
+50.0%
|
-
|
|
Jun 11
2024
|
Julian Nemirovsky |
SELL
Sale (or disposition) back to the issuer
|
Direct |
7,414
-14.56%
|
$51,898
$7.86 P/Share
|
|
Jun 11
2024
|
Julian Nemirovsky |
BUY
Exercise of conversion of derivative security
|
Direct |
24,712
+32.67%
|
-
|
|
Jun 11
2024
|
Holly L. Phillips |
SELL
Sale (or disposition) back to the issuer
|
Direct |
7,414
-14.56%
|
$51,898
$7.86 P/Share
|
|
Jun 11
2024
|
Holly L. Phillips |
BUY
Exercise of conversion of derivative security
|
Direct |
24,712
+32.67%
|
-
|
|
Jun 11
2024
|
Joseph W Marshall Iii |
SELL
Sale (or disposition) back to the issuer
|
Direct |
7,414
-3.31%
|
$51,898
$7.86 P/Share
|
|
Jun 11
2024
|
Joseph W Marshall Iii |
BUY
Exercise of conversion of derivative security
|
Direct |
24,712
+9.95%
|
-
|
|
Jun 11
2024
|
Gary J. Nabel |
SELL
Sale (or disposition) back to the issuer
|
Direct |
7,414
-14.56%
|
$51,898
$7.86 P/Share
|
|
Jun 11
2024
|
Gary J. Nabel |
BUY
Exercise of conversion of derivative security
|
Direct |
24,712
+32.67%
|
-
|
|
Jun 11
2024
|
Harold Eugene Ford Jr. |
SELL
Sale (or disposition) back to the issuer
|
Direct |
7,414
-30.0%
|
$51,898
$7.86 P/Share
|
|
Jun 11
2024
|
Harold Eugene Ford Jr. |
BUY
Exercise of conversion of derivative security
|
Direct |
24,712
+50.0%
|
-
|
|
Jun 11
2024
|
Evan A. Knisely |
SELL
Sale (or disposition) back to the issuer
|
Direct |
7,414
-30.0%
|
$51,898
$7.86 P/Share
|
|
Jun 11
2024
|
Evan A. Knisely |
BUY
Exercise of conversion of derivative security
|
Direct |
24,712
+50.0%
|
-
|
|
Jun 11
2024
|
Jaymie A Durnan |
SELL
Sale (or disposition) back to the issuer
|
Direct |
7,414
-11.25%
|
$51,898
$7.86 P/Share
|
|
Jun 11
2024
|
Jaymie A Durnan |
BUY
Exercise of conversion of derivative security
|
Direct |
24,712
+27.26%
|
-
|
|
Mar 25
2024
|
Larry R. Miller General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
19,040
-38.13%
|
$152,320
$8.35 P/Share
|
|
Mar 25
2024
|
Larry R. Miller General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
49,940
+50.0%
|
-
|
|
Jun 13
2023
|
Jaymie A Durnan |
SELL
Sale (or disposition) back to the issuer
|
Direct |
4,386
-9.62%
|
$26,316
$6.07 P/Share
|
|
Jun 13
2023
|
Jaymie A Durnan |
BUY
Exercise of conversion of derivative security
|
Direct |
14,620
+24.28%
|
-
|
Last 12 Months Summary
Buy / Acquisition
248K
Shares
From
9
Insiders
| Exercise of conversion of derivative security | 198K shares |
|---|---|
| Grant, award, or other acquisition | 49.9K shares |
Sell / Disposition
78.4K
Shares
From
9
Insiders
| Sale (or disposition) back to the issuer | 59.3K shares |
|---|---|
| Payment of exercise price or tax liability | 19K shares |